RMI Partners

company

About

RMI Partners is VC firm focused on breakthrough developments of pharmaceutical products and technologies based in the U.S. and Russia.

  • 11 - 50

Highlights

Details

Industries
Biotechnology,Life Science,Venture Capital
Founded date
Jan 1, 2012
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

RMI Partners is a venture company established in 2012, with a strategic focus on investments supporting the development of innovative biopharmaceutical products and medical technologies. In Eastern Europe and Russia, RMI Partners is one of the largest investors in life sciences. The company makes global investments in a variety of therapeutic areas.

RMI Partners is currently managing the venture fund RusnanoMedInvest (RMI, a subsidiary of JSC RUSNANO), which was created in 2012 to develop innovative projects in the field of medicine and pharmaceutics. RMI’s portfolio includes companies from Russia, USA, UK and Israel, specializing in the development and marketing of innovative pharmaceutical and medical technologies, many of which successfully completed an initial public offering (IPO) on NASDAQ, or were purchased by strategic buyers.

Investments

Number of Investments
Number of Lead Investments
4
0
RMI Partners has made 4 investments. Their most recent investment was on Jan 5, 2015, when Transcend Medical raised $7.20M.
Date Company Name
Round Money Raised Industry Lead Investor
Series Unknown $7.20M Health Care
Oct 6, 2014 Miramar Labs
Series D $26M Health Care
Series C $29M Health Care
Series Unknown $11.43M Biopharma